What factors are contributing to the 30% decline in sales of Gore's vascular grafts in European markets since last year?

Introduction

The 30% decline in sales of Gore's vascular grafts in European markets since last year is a significant issue that requires a thorough root cause analysis. To address this problem, I'll employ a systematic approach to identify, validate, and address the underlying factors contributing to this sales decline. My analysis will cover both immediate and long-term implications, ensuring a comprehensive understanding of the situation.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be a regulatory change. Has there been any new EU medical device regulation affecting vascular grafts?

Why it matters: Regulatory changes can significantly impact product availability and sales. Expected answer: Yes, there's been a new MDR implementation. Impact on approach: If confirmed, we'd need to focus on compliance and market access strategies.

• Considering market dynamics, I'm curious about competitor activity. Have any new vascular graft products entered the European market recently?

Why it matters: New competitors could be capturing market share. Expected answer: A new entrant with an innovative graft design has gained traction. Impact on approach: We'd need to analyze our product positioning and differentiation.

• Thinking about internal factors, I'm wondering about our sales and marketing efforts. Has there been any significant change in our go-to-market strategy or sales team structure in Europe?

Why it matters: Changes in sales approach could impact customer relationships and sales performance. Expected answer: There's been a restructuring of the European sales team. Impact on approach: We'd need to evaluate the effectiveness of the new structure and identify any gaps.

• Considering product performance, I'm curious about any changes in clinical outcomes. Have there been any reports of adverse events or changes in long-term efficacy data for our vascular grafts?

Why it matters: Clinical performance directly impacts physician preference and product adoption. Expected answer: No significant changes in clinical outcomes have been reported. Impact on approach: We'd focus more on market dynamics and competitive factors rather than product performance issues.